Cargando…

Effect of Low Complement C4 on Clinical Characteristics of Patients with First-Episode Neuromyelitis Optica Spectrum Disorder

PURPOSE: To describe and compare the clinical features of patients with first-episode neuromyelitis optica spectrum disorder (NMOSD) in a normal complement C4 group and a low complement C4 group, and explore the mechanism by which low complement C4 affects the clinical features of patients with NMOS...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Chunyang, Zhao, Yi, Xie, Haojie, Zhou, Yongyan, Duan, Ranran, Li, Yanfei, Jia, Yanjie, Peng, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434927/
https://www.ncbi.nlm.nih.gov/pubmed/34522097
http://dx.doi.org/10.2147/NDT.S322789
_version_ 1783751706544177152
author Pan, Chunyang
Zhao, Yi
Xie, Haojie
Zhou, Yongyan
Duan, Ranran
Li, Yanfei
Jia, Yanjie
Peng, Tao
author_facet Pan, Chunyang
Zhao, Yi
Xie, Haojie
Zhou, Yongyan
Duan, Ranran
Li, Yanfei
Jia, Yanjie
Peng, Tao
author_sort Pan, Chunyang
collection PubMed
description PURPOSE: To describe and compare the clinical features of patients with first-episode neuromyelitis optica spectrum disorder (NMOSD) in a normal complement C4 group and a low complement C4 group, and explore the mechanism by which low complement C4 affects the clinical features of patients with NMOSD. PATIENTS AND METHODS: We retrospectively analyzed clinical data of 169 aquaporin-4 (AQP4) antibody positive patients with NMOSD from the First Affiliated Hospital of Zhengzhou University from December 2013 to March 2021. Prior to treatment, the blood was drawn for detection, and the patients underwent a 3.0 Tesla MRI examination. A low complement C4 level was defined as a serum complement C4 level <0.14 g/L. Depending on whether the complement C4 level was reduced, it was divided into the normal complement C4 group and low complement C4 group. The basic demographics, clinical manifestations, laboratory examinations, and imaging findings of the two groups were compared. RESULTS: Among the 169 AQP4 antibody positive patients, 54 were low-complement C4 patients and 115 were normal. There were no significant differences in the demographics, clinical manifestations, treatment options, or admission Expanded Disability Status Scale (EDSS) score between two groups (P > 0.05). The median of discharged EDSS was the same (4 vs 4), but the difference between the two was statistically significant (P = 0.019). Compared with the normal complement C4 group, the blood uric acid level (225 vs 179; P = 0.001) and the C3 level (1.06 vs 0.87, P = 0.000) of the low complement C4 group were significantly lower. The incidence of brainstem lesions in patients with low complement C4 was higher (53.7% vs 33%, P = 0.01). CONCLUSION: The treatment effect of the first-episode AQP4 antibody positive NMOSD low complement C4 group was poor, the blood-brain barrier was more severely damaged, and the disease changes were likely to involve the brainstem.
format Online
Article
Text
id pubmed-8434927
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84349272021-09-13 Effect of Low Complement C4 on Clinical Characteristics of Patients with First-Episode Neuromyelitis Optica Spectrum Disorder Pan, Chunyang Zhao, Yi Xie, Haojie Zhou, Yongyan Duan, Ranran Li, Yanfei Jia, Yanjie Peng, Tao Neuropsychiatr Dis Treat Original Research PURPOSE: To describe and compare the clinical features of patients with first-episode neuromyelitis optica spectrum disorder (NMOSD) in a normal complement C4 group and a low complement C4 group, and explore the mechanism by which low complement C4 affects the clinical features of patients with NMOSD. PATIENTS AND METHODS: We retrospectively analyzed clinical data of 169 aquaporin-4 (AQP4) antibody positive patients with NMOSD from the First Affiliated Hospital of Zhengzhou University from December 2013 to March 2021. Prior to treatment, the blood was drawn for detection, and the patients underwent a 3.0 Tesla MRI examination. A low complement C4 level was defined as a serum complement C4 level <0.14 g/L. Depending on whether the complement C4 level was reduced, it was divided into the normal complement C4 group and low complement C4 group. The basic demographics, clinical manifestations, laboratory examinations, and imaging findings of the two groups were compared. RESULTS: Among the 169 AQP4 antibody positive patients, 54 were low-complement C4 patients and 115 were normal. There were no significant differences in the demographics, clinical manifestations, treatment options, or admission Expanded Disability Status Scale (EDSS) score between two groups (P > 0.05). The median of discharged EDSS was the same (4 vs 4), but the difference between the two was statistically significant (P = 0.019). Compared with the normal complement C4 group, the blood uric acid level (225 vs 179; P = 0.001) and the C3 level (1.06 vs 0.87, P = 0.000) of the low complement C4 group were significantly lower. The incidence of brainstem lesions in patients with low complement C4 was higher (53.7% vs 33%, P = 0.01). CONCLUSION: The treatment effect of the first-episode AQP4 antibody positive NMOSD low complement C4 group was poor, the blood-brain barrier was more severely damaged, and the disease changes were likely to involve the brainstem. Dove 2021-09-07 /pmc/articles/PMC8434927/ /pubmed/34522097 http://dx.doi.org/10.2147/NDT.S322789 Text en © 2021 Pan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Pan, Chunyang
Zhao, Yi
Xie, Haojie
Zhou, Yongyan
Duan, Ranran
Li, Yanfei
Jia, Yanjie
Peng, Tao
Effect of Low Complement C4 on Clinical Characteristics of Patients with First-Episode Neuromyelitis Optica Spectrum Disorder
title Effect of Low Complement C4 on Clinical Characteristics of Patients with First-Episode Neuromyelitis Optica Spectrum Disorder
title_full Effect of Low Complement C4 on Clinical Characteristics of Patients with First-Episode Neuromyelitis Optica Spectrum Disorder
title_fullStr Effect of Low Complement C4 on Clinical Characteristics of Patients with First-Episode Neuromyelitis Optica Spectrum Disorder
title_full_unstemmed Effect of Low Complement C4 on Clinical Characteristics of Patients with First-Episode Neuromyelitis Optica Spectrum Disorder
title_short Effect of Low Complement C4 on Clinical Characteristics of Patients with First-Episode Neuromyelitis Optica Spectrum Disorder
title_sort effect of low complement c4 on clinical characteristics of patients with first-episode neuromyelitis optica spectrum disorder
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434927/
https://www.ncbi.nlm.nih.gov/pubmed/34522097
http://dx.doi.org/10.2147/NDT.S322789
work_keys_str_mv AT panchunyang effectoflowcomplementc4onclinicalcharacteristicsofpatientswithfirstepisodeneuromyelitisopticaspectrumdisorder
AT zhaoyi effectoflowcomplementc4onclinicalcharacteristicsofpatientswithfirstepisodeneuromyelitisopticaspectrumdisorder
AT xiehaojie effectoflowcomplementc4onclinicalcharacteristicsofpatientswithfirstepisodeneuromyelitisopticaspectrumdisorder
AT zhouyongyan effectoflowcomplementc4onclinicalcharacteristicsofpatientswithfirstepisodeneuromyelitisopticaspectrumdisorder
AT duanranran effectoflowcomplementc4onclinicalcharacteristicsofpatientswithfirstepisodeneuromyelitisopticaspectrumdisorder
AT liyanfei effectoflowcomplementc4onclinicalcharacteristicsofpatientswithfirstepisodeneuromyelitisopticaspectrumdisorder
AT jiayanjie effectoflowcomplementc4onclinicalcharacteristicsofpatientswithfirstepisodeneuromyelitisopticaspectrumdisorder
AT pengtao effectoflowcomplementc4onclinicalcharacteristicsofpatientswithfirstepisodeneuromyelitisopticaspectrumdisorder